These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 39160362)

  • 1. Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases.
    Hart de Ruyter FJ; Evers MJAP; Morrema THJ; Dijkstra AA; den Haan J; Twisk JWR; de Boer JF; Scheltens P; Bouwman FH; Verbraak FD; Rozemuller AJ; Hoozemans JJM
    Acta Neuropathol; 2024 Aug; 148(1):24. PubMed ID: 39160362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.
    Robinson JL; Lee EB; Xie SX; Rennert L; Suh E; Bredenberg C; Caswell C; Van Deerlin VM; Yan N; Yousef A; Hurtig HI; Siderowf A; Grossman M; McMillan CT; Miller B; Duda JE; Irwin DJ; Wolk D; Elman L; McCluskey L; Chen-Plotkin A; Weintraub D; Arnold SE; Brettschneider J; Lee VM; Trojanowski JQ
    Brain; 2018 Jul; 141(7):2181-2193. PubMed ID: 29878075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies.
    Hart de Ruyter FJ; Morrema THJ; den Haan J; ; Twisk JWR; de Boer JF; Scheltens P; Boon BDC; Thal DR; Rozemuller AJ; Verbraak FD; Bouwman FH; Hoozemans JJM
    Acta Neuropathol; 2023 Feb; 145(2):197-218. PubMed ID: 36480077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer's disease brains: Implications for in-vivo diagnostics.
    den Haan J; Morrema THJ; Rozemuller AJ; Bouwman FH; Hoozemans JJM
    Acta Neuropathol Commun; 2018 Aug; 6(1):75. PubMed ID: 30092839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein pathology in post-mortem retina and optic nerve is specific for α-synucleinopathies.
    Hart de Ruyter FJ; Morrema THJ; den Haan J; Gase G; Twisk JWR; de Boer JF; Scheltens P; Bouwman FH; Verbraak FD; Rozemuller AJM; Hoozemans JJM
    NPJ Parkinsons Dis; 2023 Aug; 9(1):124. PubMed ID: 37640753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
    Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
    Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-beta and phosphorylated tau in post-mortem Alzheimer's disease retinas.
    den Haan J; Morrema THJ; Verbraak FD; de Boer JF; Scheltens P; Rozemuller AJ; Bergen AAB; Bouwman FH; Hoozemans JJ
    Acta Neuropathol Commun; 2018 Dec; 6(1):147. PubMed ID: 30593285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
    Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
    Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau seeds occur before earliest Alzheimer's changes and are prevalent across neurodegenerative diseases.
    Manca M; Standke HG; Browne DF; Huntley ML; Thomas OR; Orrú CD; Hughson AG; Kim Y; Zhang J; Tatsuoka C; Zhu X; Hiniker A; Coughlin DG; Galasko D; Kraus A
    Acta Neuropathol; 2023 Jul; 146(1):31-50. PubMed ID: 37154939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathological changes associated with aberrant cerebrospinal fluid p-tau181 and Aβ42 in Alzheimer's disease and other neurodegenerative diseases.
    Kurihara M; Matsubara T; Morimoto S; Arakawa A; Ohse K; Kanemaru K; Iwata A; Murayama S; Saito Y
    Acta Neuropathol Commun; 2024 Mar; 12(1):48. PubMed ID: 38539238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct molecular patterns of TDP-43 pathology in Alzheimer's disease: relationship with clinical phenotypes.
    Tomé SO; Vandenberghe R; Ospitalieri S; Van Schoor E; Tousseyn T; Otto M; von Arnim CAF; Thal DR
    Acta Neuropathol Commun; 2020 Apr; 8(1):61. PubMed ID: 32349792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series.
    Kovacs GG; Milenkovic I; Wöhrer A; Höftberger R; Gelpi E; Haberler C; Hönigschnabl S; Reiner-Concin A; Heinzl H; Jungwirth S; Krampla W; Fischer P; Budka H
    Acta Neuropathol; 2013 Sep; 126(3):365-84. PubMed ID: 23900711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathies.
    Pires G; McElligott S; Drusinsky S; Halliday G; Potier MC; Wisniewski T; Drummond E
    Acta Neuropathol Commun; 2019 Dec; 7(1):195. PubMed ID: 31796108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downstream effects of polypathology on neurodegeneration of medial temporal lobe subregions.
    Wisse LEM; Ravikumar S; Ittyerah R; Lim S; Lane J; Bedard ML; Xie L; Das SR; Schuck T; Grossman M; Lee EB; Tisdall MD; Prabhakaran K; Detre JA; Mizsei G; Trojanowski JQ; Artacho-Pérula E; de Iñiguez de Onzono Martin MM; M Arroyo-Jiménez M; Muñoz Lopez M; Molina Romero FJ; P Marcos Rabal M; Cebada Sánchez S; Delgado González JC; de la Rosa Prieto C; Córcoles Parada M; Wolk DA; Irwin DJ; Insausti R; Yushkevich PA
    Acta Neuropathol Commun; 2021 Jul; 9(1):128. PubMed ID: 34289895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration.
    Chai YL; Chong JR; Weng J; Howlett D; Halsey A; Lee JH; Attems J; Aarsland D; Francis PT; Chen CP; Lai MKP
    Brain Pathol; 2019 Jan; 29(1):63-74. PubMed ID: 30051532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of Tau and α-Synuclein Pathology in the Visual System.
    Rahimi J; Milenkovic I; Kovacs GG
    J Parkinsons Dis; 2015; 5(2):333-40. PubMed ID: 25737267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological tau deposition in Motor Neurone Disease and frontotemporal lobar degeneration associated with TDP-43 proteinopathy.
    Behrouzi R; Liu X; Wu D; Robinson AC; Tanaguchi-Watanabe S; Rollinson S; Shi J; Tian J; Hamdalla HH; Ealing J; Richardson A; Jones M; Pickering-Brown S; Davidson YS; Strong MJ; Hasegawa M; Snowden JS; Mann DM
    Acta Neuropathol Commun; 2016 Mar; 4():33. PubMed ID: 27036121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies.
    Wetering JV; Geut H; Bol JJ; Galis Y; Timmermans E; Twisk JWR; Hepp DH; Morella ML; Pihlstrom L; Lemstra AW; Rozemuller AJM; Jonkman LE; van de Berg WDJ
    Acta Neuropathol Commun; 2024 May; 12(1):73. PubMed ID: 38715119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception.
    Moda F; Ciullini A; Dellarole IL; Lombardo A; Campanella N; Bufano G; Cazzaniga FA; Giaccone G
    Front Biosci (Landmark Ed); 2023 Oct; 28(10):255. PubMed ID: 37919089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients.
    Ho CY; Troncoso JC; Knox D; Stark W; Eberhart CG
    Brain Pathol; 2014 Jan; 24(1):25-32. PubMed ID: 23714377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.